Observational studyMedicine2020

Assessing the quality of life of patients with metastatic castration-resistant prostate cancer with bone metastases receiving [223Ra]RaCl2 therapy.

Miriam Sraieb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.